北京市金杜律师事务所上海分所 关于上海洗霸科技股份有限公司 2025 年第一次临时股东大会之法律意见书 致：上海洗霸科技股份有限公司 北京市金杜律师事务所上海分所（以下简称本所）接受上海洗霸科技股份有 限公司（以下简称公司或上海洗霸）委托，根据《中华人民共和国证券法》（以 下简称《证券法》）、《中华人民共和国公司法》（以下简称《公司法》）、中国证券 监督管理委员会（以下简称中国证监会）《上市公司股东会规则》（以下简称《股 东会规则》）等中华人民共和国境内（以下简称中国境内，为本法律意见书之目 的，不包括中国香港特别行政区、中国澳门特别行政区和中国台湾地区）现行有 效的法律、行政法规、规章和规范性文件和现行有效的公司章程有关规定，指派 律师出席了公司于 2025 年 5 月 26 日召开的 2025 年第一次临时股东大会（以下 简称本次股东大会），并就本次股东大会相关事项出具本法律意见书。 为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1. 经公司 2024 年第二次临时股东大会审议通过的《上海洗霸科技股份有限 公司章程》（以下简称《公司章程》）； 2. 公司 2025 年 5 月 10 ...

华西证券表示，固态电池具备诸多优势，包括更高的安全性、能量密度、循环寿命、机械强度，更宽的 温度适应性和材料选择性等，其中高安全和高容量为固态电池核心优势。受益标的：1)材料端：宁德时 代（300750）、比亚迪（002594）、亿纬锂能（300014）、鹏辉能源（300438）、天奈科技 （688116）、厦钨新能（688778）、当升科技（300073）、容百科技（688005）、三祥新材 （603663）、东方锆业（002167）、恩捷股份（002812）、星源材质（300568）、元力股份 （300174）、上海洗霸（603200）、天赐材料（002709）、中科电气（300035）、翔丰华、璞泰来 （603659）、金博股份等。2)设备端：纳科诺尔、曼恩斯特等。 国海证券认为，全固态电池产业化进程加速，材料端重点关注硫化物路线，设备端核心增量在 于"干""压""叠"。1)前段：变化最为明显，干法电极设备及固态电解质干法成膜设备有望逐步替代传统 湿法设备，主要包括：纤维化设备、辊压机；2)中段：仅可用叠片机(搭配软包)，且对叠片机的精度和 稳定性要求提升，此外无需注液机，新增等静压机核心致密化设备；3 ...

Meeting Overview - The annual general meeting of Shanghai Xiba Technology Co., Ltd. was held on May 22, 2025, at the Baishu Building, Shanghai [1] - The meeting was conducted with a combination of on-site and online voting, presided over by the chairman Wang Wei [1] Attendance - All 7 current directors attended the meeting, while 2 out of 3 supervisors were present, with one supervisor absent due to work commitments [2] - The company secretary Wang Shanjiong also attended the meeting [2] Resolutions Passed - The following resolutions were approved during the meeting: 1. 2024 Annual Work Report of the Board [3] 2. 2024 Annual Work Report of the Supervisory Board [3] 3. 2024 Annual Report and Summary [4] 4. 2024 Financial Settlement Report [4] 5. 2025 Financial Budget Proposal [4] 6. 2024 Profit Distribution Proposal [4] 7. 2025 Non-Independent Director Remuneration Proposal [4] 8. 2025 Independent Director Remuneration Proposal [4] 9. 2025 Supervisor Remuneration Proposal [4] 10. Reappointment of the auditing firm for 2025 [5] 11. Proposal for comprehensive credit facilities from banks for 2025 [5] Voting and Legal Compliance - All resolutions were ordinary resolutions requiring more than half of the voting rights held by attending shareholders for approval [5] - Related shareholders abstained from voting on certain proposals, ensuring compliance with legal and regulatory requirements [5] - The meeting was witnessed by lawyers from Beijing King & Wood Mallesons Shanghai Office, confirming that the meeting's procedures and voting results were legally valid [6]

为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1. 经公司 2024 年第二次临时股东大会审议通过的《上海洗霸科技股份有限 公司章程》（以下简称《公司章程》）； 2. 公司 2025 年 4 月 29 日刊登于上海证券交易所网站的《上海洗霸科技股 份有限公司第五届董事会第十四次会议决议公告》《上海洗霸科技股份 有限公司第五届监事会第十一次会议决议公告》； 3. 公司 2025 年 4 月 29 日刊登于上海证券交易所网站的《上海洗霸科技股 份有限公司关于召开 2024 年年度股东大会的通知》（以下简称《2024 年 度股东大会通知》）； 4. 公司本次股东大会股权登记日的股东名册； 5. 出席现场会议的股东及其他人员的到会登记记录及凭证资料； 6. 上证所信息网络有限公司提供的本次股东大会网络投票情况的统计结果； 7. 公司本次股东大会议案及涉及相关议案内容的公告等文件； 北京市金杜律师事务所上海分所 关于上海洗霸科技股份有限公司 2024 年年度股东大会之法律意见书 致：上海洗霸科技股份有限公司 北京市金杜律师事务所上海分所（以下简称本所）接受上海洗霸科技股份有 限公司（以下简称公司 ...

证券代码：603200 证券简称：上海洗霸 公告编号：2025-027 上海洗霸科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 表决情况： | 股东类型 | 同意 | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | | | 票数 | 比例（%） | 票数 | 比例 | 票数 | 比例 | | | | | | （%） | | （%） | | A 股 | 84,999,633 | 99.9554 | 33,300 | 0.0392 | 4,645 | 0.0055 | 2、 议案名称：《关于监事会 2024 年度工作报告的议案》 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 192 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 85,037,578 | | 3、出席会议的股东所持有表决权股份数占公司有表决权 ...

Group 1 - Solid-state battery concept stocks have been declining, with Ningxin New Materials and Lingge Technology dropping over 10% [1] - Other companies such as Wuhan Land Electric, Honggong Technology, Liwang Co., Lingpai Technology, Naconor, Jinyinhai, Liyuanheng, Betterray, and Shanghai Xiba have also seen declines of over 5% [1]

Core Viewpoint - Shanghai Xiba plans to acquire patents and establish two holding subsidiaries to promote the industrialization of high-energy hydrogen-electric hybrid power systems and special solid-state lithium-ion battery technologies, enhancing its position in the new energy sector [1][2]. Summary by Sections Patent Acquisition - Shanghai Xiba will purchase four invention patents and one utility model patent from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, for a total of 25 million yuan (approximately 3.5 million USD) [1]. Subsidiary Establishment - The company intends to set up two holding subsidiaries with a registered capital of 10 million yuan (approximately 1.4 million USD) each, in collaboration with its core technology and management teams [1][2]. Business Strategy - The establishment of these subsidiaries aligns with the company's business and strategic planning, aiming to integrate technical advantages and resources from partners to enhance its capabilities and competitiveness in the new energy sector [2]. Current Business Context - Shanghai Xiba's main business involves customized water treatment chemicals and equipment, with a recent focus on advanced materials for solid-state batteries [3]. The company has completed the design of high-energy soft-pack lithium-ion solid-state batteries, which are now in small-scale production [3]. Financial Performance - In Q1 2025, the company reported a significant decline in net profit by 51% year-on-year to 9.83 million yuan (approximately 1.4 million USD), with a 17% drop in revenue, primarily due to the lack of high-margin projects compared to the previous year [4]. Future Outlook - Despite substantial investments in advanced materials, the business has not yet generated stable, large-scale revenue [5]. The company plans to focus on its core water treatment services while gradually reducing its involvement in engineering construction, aiming to develop a second growth curve in the new energy advanced materials sector [4].

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]

证券代码：603200 证券简称：上海洗霸 公告编号：2025-026 上海洗霸科技股份有限公司 关于购买专利资产 及对外投资设立控股子公司的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 重要内容提示： 上海洗霸科技股份有限公司（以下简称"公司"）与中国科学 院大连化学物理研究所拟签订《高比能氢电混动电源系统技术转让 （专利权）合同》，约定以人民币 2,000 万元购买 3 项发明专利和 1 项实用新型专利的专利权；拟签订《特种固态锂离子电池技术技术 转让（专利权）合同》，约定以人民币 500 万元购买 2 项发明专利的 专利权。 为推动前述高比能氢电混动电源系统和特种固态锂离子电池 技术的产业化发展，公司拟分别与相关核心技术团队、管理团队合 资设立公司控股的子公司，注册资本均为 1,000 万元人民币。 本次交易事项不属于关联交易，也不构成重大资产重组。 相关风险提示：结合国内外相关市场的竞争形势，随着新能 源领域相关技术的不断革新和新生产工艺的出现，上述技术在产业 化、客户认可、市场竞争、技术替代等方面均面临不确 ...

Group 1 - The company Shanghai Xiba plans to acquire the patent rights for three invention patents and one utility model patent from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences for 20 million yuan [1] - Additionally, the company intends to purchase the patent rights for two invention patents for 5 million yuan [1] - The company plans to establish two holding subsidiaries with a registered capital of 10 million yuan each in partnership with its core technology and management teams to promote the industrialization of related technologies [1] Group 2 - The transactions do not constitute related party transactions or major asset restructuring [1]